{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T19:12:34Z","timestamp":1794251554459,"version":"4.9.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T00:00:00Z","timestamp":1582761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T00:00:00Z","timestamp":1582761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81701281"],"award-info":[{"award-number":["81701281"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2016YFC1306000"],"award-info":[{"award-number":["2016YFC1306000"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81501182"],"award-info":[{"award-number":["81501182"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["NS095279"],"award-info":[{"award-number":["NS095279"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Spinocerebellar ataxias 17 (SCA17) is caused by polyglutamine (polyQ) expansion in the TATA box-binding protein (TBP). The selective neurodegeneration in the cerebellum in SCA17 raises the question of why ubiquitously expressed polyQ proteins can cause neurodegeneration in distinct brain regions in different polyQ diseases. By expressing mutant <jats:italic>TBP<\/jats:italic> in different brain regions in adult wild-type mice via stereotaxic injection of adeno-associated virus, we found that adult cerebellar neurons are particularly vulnerable to mutant TBP. In SCA17 knock-in mice, mutant TBP inhibits SP1-mediated gene transcription to down-regulate INPP5A, a protein that is highly abundant in the cerebellum. CRISPR\/Cas9-mediated deletion of <jats:italic>Inpp5a<\/jats:italic> in the cerebellum of wild-type mice leads to Purkinje cell degeneration, and <jats:italic>Inpp5a<\/jats:italic> overexpression decreases inositol 1,4,5-trisphosphate (IP<jats:sub>3<\/jats:sub>) levels and ameliorates Purkinje cell degeneration in SCA17 knock-in mice. Our findings demonstrate the important contribution of a tissue-specific protein to the polyQ protein-mediated selective neuropathology.<\/jats:p>","DOI":"10.1038\/s41467-020-14931-8","type":"journal-article","created":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T11:04:32Z","timestamp":1582801472000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Cerebellum-enriched protein INPP5A contributes to selective neuropathology in mouse model of spinocerebellar ataxias type 17"],"prefix":"10.1038","volume":"11","author":[{"given":"Qiong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siying","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beisha","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongcheng","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1775-6536","authenticated-orcid":false,"given":"Shihua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,27]]},"reference":[{"key":"14931_CR1","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1146\/annurev.neuro.29.051605.113042","volume":"30","author":"HT Orr","year":"2007","unstructured":"Orr, H. T. & Zoghbi, H. Y. Trinucleotide repeat disorders. Annu. Rev. Neurosci. 30, 575\u2013621 (2007).","journal-title":"Annu. Rev. Neurosci."},{"key":"14931_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41572-019-0074-3","volume":"5","author":"T Klockgether","year":"2019","unstructured":"Klockgether, T., Mariotti, C. & Paulson, H. L. Spinocerebellar ataxia. Nat. Rev. Dis. Prim. 5, 24 (2019).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"14931_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neuron.2011.06.031","volume":"71","author":"S Saxena","year":"2011","unstructured":"Saxena, S. & Caroni, P. Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration. Neuron 71, 35\u201348 (2011).","journal-title":"Neuron"},{"key":"14931_CR4","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel, J. P. et al. Neuropathological classification of Huntington\u2019s disease. J. Neuropathol. Exp. Neurol. 44, 559\u2013577 (1985).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"14931_CR5","doi-asserted-by":"publisher","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","volume":"1","author":"GP Bates","year":"2015","unstructured":"Bates, G. P. et al. Huntington disease. Nat. Rev. Dis. Prim. 1, 15005 (2015).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"14931_CR6","doi-asserted-by":"publisher","first-page":"7425","DOI":"10.1074\/jbc.R800041200","volume":"284","author":"HY Zoghbi","year":"2009","unstructured":"Zoghbi, H. Y. & Orr, H. T. Pathogenic mechanisms of a polyglutamine-mediated neurodegenerative disease, spinocerebellar ataxia type 1. J. Biol. Chem. 284, 7425\u20137429 (2009).","journal-title":"J. Biol. Chem."},{"key":"14931_CR7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2174\/1570159X15666170529104000","volume":"16","author":"E Shimobayashi","year":"2018","unstructured":"Shimobayashi, E. & Kapfhammer, J. P. Calcium signaling, PKC gamma, IP3R1 and CAR8 link spinocerebellar ataxias and Purkinje cell dendritic development. Curr. Neuropharmacol. 16, 151\u2013159 (2018).","journal-title":"Curr. Neuropharmacol."},{"key":"14931_CR8","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1093\/hmg\/10.14.1441","volume":"10","author":"K Nakamura","year":"2001","unstructured":"Nakamura, K. et al. SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. Hum. Mol. Genet. 10, 1441\u20131448 (2001).","journal-title":"Hum. Mol. Genet."},{"key":"14931_CR9","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1093\/brain\/124.10.1939","volume":"124","author":"H Fujigasaki","year":"2001","unstructured":"Fujigasaki, H. et al. CAG repeat expansion in the TATA box-binding protein gene causes autosomal dominant cerebellar ataxia. Brain 124, 1939\u20131947 (2001).","journal-title":"Brain"},{"key":"14931_CR10","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1093\/hmg\/8.11.2047","volume":"8","author":"R Koide","year":"1999","unstructured":"Koide, R. et al. A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: a new polyglutamine disease? Hum. Mol. Genet. 8, 2047\u20132053 (1999).","journal-title":"Hum. Mol. Genet."},{"key":"14931_CR11","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s13311-019-00762-z","volume":"16","author":"Q Liu","year":"2019","unstructured":"Liu, Q., Pan, Y., Li, X. J. & Li, S. Molecular mechanisms and therapeutics for SCA17. Neurotherapeutics 16, 1097\u20131105 (2019).","journal-title":"Neurotherapeutics"},{"key":"14931_CR12","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1146\/annurev.bi.65.070196.004005","volume":"65","author":"SK Burley","year":"1996","unstructured":"Burley, S. K. & Roeder, R. G. Biochemistry and structural biology of transcription factor IID (TFIID). Annu. Rev. Biochem. 65, 769\u2013799 (1996).","journal-title":"Annu. Rev. Biochem."},{"key":"14931_CR13","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1101\/gad.7.7b.1291","volume":"7","author":"N Hernandez","year":"1993","unstructured":"Hernandez, N. TBP, a universal eukaryotic transcription factor? Genes Dev. 7, 1291\u20131308 (1993).","journal-title":"Genes Dev."},{"key":"14931_CR14","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1126\/science.1076327","volume":"298","author":"I Martianov","year":"2002","unstructured":"Martianov, I., Viville, S. & Davidson, I. RNA polymerase II transcription in murine cells lacking the TATA binding protein. Science 298, 1036\u20131039 (2002).","journal-title":"Science"},{"key":"14931_CR15","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/ana.10676","volume":"54","author":"A Rolfs","year":"2003","unstructured":"Rolfs, A. et al. Clinical features and neuropathology of autosomal dominant spinocerebellar ataxia (SCA17). Ann. Neurol. 54, 367\u2013375 (2003).","journal-title":"Ann. Neurol."},{"key":"14931_CR16","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1152\/physrev.00006.2016","volume":"96","author":"MJ Berridge","year":"2016","unstructured":"Berridge, M. J. The inositol trisphosphate\/calcium signaling pathway in health and disease. Physiol. Rev. 96, 1261\u20131296 (2016).","journal-title":"Physiol. Rev."},{"key":"14931_CR17","doi-asserted-by":"publisher","first-page":"11676","DOI":"10.1074\/jbc.271.20.11676","volume":"271","author":"D Communi","year":"1996","unstructured":"Communi, D., Lecocq, R. & Erneux, C. Arginine 343 and 350 are two active residues involved in substrate binding by human type I D-myo-inositol 1,4,5,-trisphosphate 5-phosphatase. J. Biol. Chem. 271, 11676\u201311683 (1996).","journal-title":"J. Biol. Chem."},{"key":"14931_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/15216540210815","volume":"53","author":"CA Mitchell","year":"2002","unstructured":"Mitchell, C. A. et al. Inositol polyphosphate 5-phosphatases: lipid phosphatases with flair. IUBMB Life 53, 25\u201336 (2002).","journal-title":"IUBMB Life"},{"key":"14931_CR19","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1523\/JNEUROSCI.23-06-02193.2003","volume":"23","author":"ZX Yu","year":"2003","unstructured":"Yu, Z. X. et al. Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington\u2019s disease. J. Neurosci. 23, 2193\u20132202 (2003).","journal-title":"J. Neurosci."},{"key":"14931_CR20","doi-asserted-by":"publisher","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","volume":"1","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo, A., Frosch, M. P., Masliah, E. & Hyman, B. T. Neuropathological alterations in Alzheimer disease. Cold Spring Harb. Perspect. Med. 1, a006189 (2011).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"14931_CR21","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1523\/JNEUROSCI.3516-14.2015","volume":"35","author":"L Ben Haim","year":"2015","unstructured":"Ben Haim, L. et al. The JAK\/STAT3 pathway is a common inducer of astrocyte reactivity in Alzheimer\u2019s and Huntington\u2019s diseases. J. Neurosci. 35, 2817\u20132829 (2015).","journal-title":"J. Neurosci."},{"key":"14931_CR22","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.celrep.2015.08.060","volume":"13","author":"S Huang","year":"2015","unstructured":"Huang, S. et al. Large polyglutamine repeats cause muscle degeneration in SCA17 mice. Cell Rep. 13, 196\u2013208 (2015).","journal-title":"Cell Rep."},{"key":"14931_CR23","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1016\/S0021-9258(18)61629-1","volume":"262","author":"TM Connolly","year":"1987","unstructured":"Connolly, T. M., Bansal, V. S., Bross, T. E., Irvine, R. F. & Majerus, P. W. The metabolism of tris- and tetraphosphates of inositol by 5-phosphomonoesterase and 3-kinase enzymes. J. Biol. Chem. 262, 2146\u20132149 (1987).","journal-title":"J. Biol. Chem."},{"key":"14931_CR24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1042\/BJ20081673","volume":"419","author":"LM Ooms","year":"2009","unstructured":"Ooms, L. M. et al. The role of the inositol polyphosphate 5-phosphatases in cellular function and human disease. Biochem J. 419, 29\u201349 (2009).","journal-title":"Biochem J."},{"key":"14931_CR25","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10048-015-0450-4","volume":"16","author":"AW Yang","year":"2015","unstructured":"Yang, A. W., Sachs, A. J. & Nystuen, A. M. Deletion of Inpp5a causes ataxia and cerebellar degeneration in mice. Neurogenetics 16, 277\u2013285 (2015).","journal-title":"Neurogenetics"},{"key":"14931_CR26","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.1093\/hmg\/ddp363","volume":"18","author":"AG Shah","year":"2009","unstructured":"Shah, A. G. et al. Transcriptional dysregulation of TrkA associates with neurodegeneration in spinocerebellar ataxia type 17. Hum. Mol. Genet. 18, 4141\u20134152 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"14931_CR27","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1534\/g3.114.010355","volume":"4","author":"B Doray","year":"2014","unstructured":"Doray, B., Govero, J. & Kornfeld, S. Impact of genetic background on neonatal lethality of Gga2 gene-trap mice. G3 (Bethesda) 4, 885\u2013890 (2014).","journal-title":"G3 (Bethesda)"},{"key":"14931_CR28","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.cell.2014.09.014","volume":"159","author":"RJ Platt","year":"2014","unstructured":"Platt, R. J. et al. CRISPR-Cas9 knockin mice for genome editing and cancer modeling. Cell 159, 440\u2013455 (2014).","journal-title":"Cell"},{"issue":"Pt 5","key":"14931_CR29","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1242\/jcs.112.5.669","volume":"112","author":"CJ Speed","year":"1999","unstructured":"Speed, C. J., Neylon, C. B., Little, P. J. & Mitchell, C. A. Underexpression of the 43 kDa inositol polyphosphate 5-phosphatase is associated with spontaneous calcium oscillations and enhanced calcium responses following endothelin-1 stimulation. J. Cell Sci. 112(Pt 5), 669\u2013679 (1999).","journal-title":"J. Cell Sci."},{"key":"14931_CR30","doi-asserted-by":"publisher","first-page":"4852","DOI":"10.1002\/j.1460-2075.1996.tb00866.x","volume":"15","author":"CJ Speed","year":"1996","unstructured":"Speed, C. J., Little, P. J., Hayman, J. A. & Mitchell, C. A. Underexpression of the 43 kDa inositol polyphosphate 5-phosphatase is associated with cellular transformation. EMBO J. 15, 4852\u20134861 (1996).","journal-title":"EMBO J."},{"key":"14931_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-7-67","volume":"7","author":"L Huang","year":"2012","unstructured":"Huang, L. et al. Missense mutations in ITPR1 cause autosomal dominant congenital nonprogressive spinocerebellar ataxia. Orphanet J. Rare Dis. 7, 67 (2012).","journal-title":"Orphanet J. Rare Dis."},{"key":"14931_CR32","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/jnc.13991","volume":"141","author":"C Hisatsune","year":"2017","unstructured":"Hisatsune, C. & Mikoshiba, K. IP3 receptor mutations and brain diseases in human and rodents. J. Neurochem. 141, 790\u2013807 (2017).","journal-title":"J. Neurochem."},{"key":"14931_CR33","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1371\/journal.pgen.0030108","volume":"3","author":"J van de Leemput","year":"2007","unstructured":"van de Leemput, J. et al. Deletion at ITPR1 underlies ataxia in mice and spinocerebellar ataxia 15 in humans. PLoS Genet. 3, e108 (2007).","journal-title":"PLoS Genet."},{"key":"14931_CR34","doi-asserted-by":"publisher","first-page":"9148","DOI":"10.1523\/JNEUROSCI.0660-09.2009","volume":"29","author":"J Liu","year":"2009","unstructured":"Liu, J. et al. Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 2. J. Neurosci. 29, 9148\u20139162 (2009).","journal-title":"J. Neurosci."},{"key":"14931_CR35","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tins.2010.02.005","volume":"33","author":"S Schorge","year":"2010","unstructured":"Schorge, S., van de Leemput, J., Singleton, A., Houlden, H. & Hardy, J. Human ataxias: a genetic dissection of inositol triphosphate receptor (ITPR1)-dependent signaling. Trends Neurosci. 33, 211\u2013219 (2010).","journal-title":"Trends Neurosci."},{"key":"14931_CR36","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1046\/j.1471-4159.1995.64030953.x","volume":"64","author":"T Furuichi","year":"1995","unstructured":"Furuichi, T. & Mikoshiba, K. Inositol 1, 4, 5-trisphosphate receptor-mediated Ca2+ signaling in the brain. J. Neurochem. 64, 953\u2013960 (1995).","journal-title":"J. Neurochem."},{"key":"14931_CR37","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/978-1-4020-6191-2_11","volume":"45","author":"I Bezprozvanny","year":"2007","unstructured":"Bezprozvanny, I. Inositol 1,4,5-tripshosphate receptor, calcium signalling and Huntington\u2019s disease. Subcell. Biochem. 45, 323\u2013335 (2007).","journal-title":"Subcell. Biochem."},{"key":"14931_CR38","doi-asserted-by":"publisher","first-page":"12786","DOI":"10.1523\/JNEUROSCI.1643-12.2012","volume":"32","author":"AW Kasumu","year":"2012","unstructured":"Kasumu, A. W., Liang, X., Egorova, P., Vorontsova, D. & Bezprozvanny, I. Chronic suppression of inositol 1,4,5-triphosphate receptor-mediated calcium signaling in cerebellar purkinje cells alleviates pathological phenotype in spinocerebellar ataxia 2 mice. J. Neurosci. 32, 12786\u201312796 (2012).","journal-title":"J. Neurosci."},{"key":"14931_CR39","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1097\/WCO.0b013e3282f12074","volume":"20","author":"EJ Wild","year":"2007","unstructured":"Wild, E. J. & Tabrizi, S. J. Huntington\u2019s disease phenocopy syndromes. Curr. Opin. Neurol. 20, 681\u2013687 (2007).","journal-title":"Curr. Opin. Neurol."},{"key":"14931_CR40","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1128\/MCB.22.5.1277-1287.2002","volume":"22","author":"SH Li","year":"2002","unstructured":"Li, S. H. et al. Interaction of Huntington disease protein with transcriptional activator Sp1. Mol. Cell. Biol. 22, 1277\u20131287 (2002).","journal-title":"Mol. Cell. Biol."},{"key":"14931_CR41","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1038\/nn2011","volume":"10","author":"MJ Friedman","year":"2007","unstructured":"Friedman, M. J. et al. Polyglutamine domain modulates the TBP-TFIIB interaction: implications for its normal function and neurodegeneration. Nat. Neurosci. 10, 1519\u20131528 (2007).","journal-title":"Nat. Neurosci."},{"key":"14931_CR42","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1172\/JCI92087","volume":"127","author":"S Yang","year":"2017","unstructured":"Yang, S. et al. CRISPR\/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington\u2019s disease. J. Clin. Invest. 127, 2719\u20132724 (2017).","journal-title":"J. Clin. Invest."},{"key":"14931_CR43","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.neuron.2013.12.002","volume":"81","author":"S Yang","year":"2014","unstructured":"Yang, S., Huang, S., Gaertig, M. A., Li, X. J. & Li, S. Age-dependent decrease in chaperone activity impairs MANF expression, leading to Purkinje cell degeneration in inducible SCA17 mice. Neuron 81, 349\u2013365 (2014).","journal-title":"Neuron"},{"key":"14931_CR44","doi-asserted-by":"publisher","first-page":"9550","DOI":"10.1523\/JNEUROSCI.1418-17.2017","volume":"37","author":"Y Hong","year":"2017","unstructured":"Hong, Y., Zhao, T., Li, X. J. & Li, S. Mutant Huntingtin inhibits alphaB-crystallin expression and impairs exosome secretion from astrocytes. J. Neurosci. 37, 9550\u20139563 (2017).","journal-title":"J. Neurosci."},{"key":"14931_CR45","doi-asserted-by":"publisher","first-page":"E7803","DOI":"10.1073\/pnas.1710549114","volume":"114","author":"T Zhao","year":"2017","unstructured":"Zhao, T., Hong, Y., Yin, P., Li, S. & Li, X. J. Differential HspBP1 expression accounts for the greater vulnerability of neurons than astrocytes to misfolded proteins. Proc. Natl Acad. Sci. USA 114, E7803\u2013E7811 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-14931-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-14931-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-14931-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T18:51:25Z","timestamp":1670266285000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-14931-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,27]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["14931"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-14931-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,27]]},"assertion":[{"value":"17 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1101"}}